Global Longlife Hospital and Research Ltd Financials
Company Logo

Global Longlife Hospital and Research Ltd Financial Statement

Global Longlife Hospital and Research Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Mar 2023
Revenue11.87
Operating Expense9.44
Net Profit1.07
Net Profit Margin9.01
Earning Per Share1.05
EBIDTA2.14
Effective Tax Rate11.52

Global Longlife Hospital and Research Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Total Revenue Annual13.51
Operating Expenses Annual13.83
Operating Profit Annual-0.25
Interest Annual0.77
Depreciation1.25
Net Profit Annual-2.19
Tax Annual-0.08

Global Longlife Hospital and Research Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Cash Flow at the Beginning3.60
Cash Flow from Operations-5.07
Cash Flow from Investing-0.82
Cash Flow from Financing2.67
Cash Flow at the End0.39

Global Longlife Hospital and Research Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
PBDIT Margin (%)-1.63
PBIT Margin (%)-10.88
PBT Margin (%)2.74
Net PROFIT Margin (%)-16.21
Return On Networth / Equity (%)TBA
Return On Networth /Employed (%)TBA
Return On Assets (%)-3.89
Total Debt / Equity (X)0.24
Asset Turnover Ratio (%)0.24

Global Longlife Hospital and Research Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Fixed Assets Annual17.27
Total Current Assets Annual3.92
Non Current Assets Annual37.81
Total Shareholders Funds Annual25.93
Total Assets Annual41.73

Global Longlife Hospital and Research Ltd Earning Calls

No Data Availabe

Get Your FAQs Right

As of Nov 5, 2024, Global Longlife Hospital and Research Ltd has a market capitalization of 41 Cr. Value Research classifies it as a Micro-Cap company.
Yes, Global Longlife Hospital and Research Ltd is debt-free with a debt-to-equity ratio of 0.49.
In FY 2023 , Global Longlife Hospital and Research Ltd recorded a total revenue of approximately 13.51 Cr marking a significant milestone in the company's financial performance.
Global Longlife Hospital and Research Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately Infinity% and -0.4% annually, respectively..
Global Longlife Hospital and Research Ltd's current PE ratio is -18.72.
Global Longlife Hospital and Research Ltd's ROCE averaged 9.2% from the FY ending March 2022 to 2024, with a median of 4.2%. It peaked at 27.3% in March 2022, reflecting strong capital efficiency over the period..
Global Longlife Hospital and Research Ltd's latest EBIT is Rs. -1.50 Cr, surpassing the average EBIT of Rs. 2.91 Cr over the 5 years..